DE602005020694D1 - Pharmazeutische zusammensetzung mit drospirenon und ethinylöstradiol - Google Patents

Pharmazeutische zusammensetzung mit drospirenon und ethinylöstradiol

Info

Publication number
DE602005020694D1
DE602005020694D1 DE602005020694T DE602005020694T DE602005020694D1 DE 602005020694 D1 DE602005020694 D1 DE 602005020694D1 DE 602005020694 T DE602005020694 T DE 602005020694T DE 602005020694 T DE602005020694 T DE 602005020694T DE 602005020694 D1 DE602005020694 D1 DE 602005020694D1
Authority
DE
Germany
Prior art keywords
drospirenone
pharmaceutical composition
ethinyl estradiol
ethinyl
estradiol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005020694T
Other languages
English (en)
Inventor
Carlos Ariel Sandrone
Jose Mario Sakson
Basaistegui Maria Del Carmen Cajarville
Pomi Jose Daniel Larrosa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Liconsa SA
Original Assignee
Laboratorios Liconsa SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005020694(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Liconsa SA filed Critical Laboratorios Liconsa SA
Publication of DE602005020694D1 publication Critical patent/DE602005020694D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602005020694T 2004-08-09 2005-08-02 Pharmazeutische zusammensetzung mit drospirenon und ethinylöstradiol Active DE602005020694D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04103837A EP1625849A1 (de) 2004-08-09 2004-08-09 Pharmazeutische Zubereitung enthaltend Drospirenon und Ethinylestradiol
PCT/EP2005/053759 WO2006015956A1 (en) 2004-08-09 2005-08-02 Pharmaceutical composition comprising drospirenone and ethynylestradiol

Publications (1)

Publication Number Publication Date
DE602005020694D1 true DE602005020694D1 (de) 2010-05-27

Family

ID=34929434

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005020694T Active DE602005020694D1 (de) 2004-08-09 2005-08-02 Pharmazeutische zusammensetzung mit drospirenon und ethinylöstradiol

Country Status (20)

Country Link
US (1) US20090227546A1 (de)
EP (2) EP1625849A1 (de)
JP (1) JP2008509195A (de)
KR (1) KR20070045247A (de)
CN (1) CN101022811B (de)
AR (1) AR045576A1 (de)
AT (1) ATE464053T1 (de)
AU (1) AU2005271206B2 (de)
BR (1) BRPI0513938B8 (de)
CA (1) CA2574997A1 (de)
DE (1) DE602005020694D1 (de)
ES (1) ES2344356T3 (de)
HK (1) HK1109579A1 (de)
IL (1) IL180899A0 (de)
MA (1) MA28844B1 (de)
NO (1) NO20071297L (de)
RU (1) RU2007108666A (de)
UA (1) UA87513C2 (de)
WO (1) WO2006015956A1 (de)
ZA (1) ZA200702038B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5649305B2 (ja) * 2006-12-20 2015-01-07 テバ ウィメンズ ヘルス インコーポレイテッド プロゲスチンを含む口腔内崩壊性固体剤形ならびにその製造方法および使用方法
HUP0700826A3 (en) * 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
KR102329271B1 (ko) 2009-04-01 2021-11-22 바이알 - 포르텔라 앤드 씨에이 에스에이 니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
CA2757418C (en) * 2009-04-01 2021-06-15 Bial - Portela & Ca., S.A. Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) * 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
CN102274235B (zh) * 2011-06-27 2013-03-13 潍坊中狮制药有限公司 一种新的避孕药物组合及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US6027747A (en) * 1997-11-11 2000-02-22 Terracol; Didier Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
MXPA02002043A (es) * 1999-08-31 2003-08-20 Schering Ag Composicion farmaceutica de etinilestradiol y drospirenona para el uso como anticonceptivo.
EP1380301B1 (de) * 1999-08-31 2009-01-14 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Kombination von Ethinylestradiol und Drospirenon als empfängnisverhütendes Mittel
ES2327538T3 (es) * 2000-12-14 2009-10-30 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Proceso para preparar productos de hormona esteroidea que comprenden un agente estabilizante en forma no cristalina.
EP1216712A1 (de) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Einschlusskomplexe von Drospirenone und Cyclodextrinen

Also Published As

Publication number Publication date
US20090227546A1 (en) 2009-09-10
UA87513C2 (ru) 2009-07-27
ES2344356T3 (es) 2010-08-25
EP1625849A1 (de) 2006-02-15
KR20070045247A (ko) 2007-05-02
AU2005271206A1 (en) 2006-02-16
BRPI0513938A (pt) 2008-05-20
JP2008509195A (ja) 2008-03-27
AR045576A1 (es) 2005-11-02
NO20071297L (no) 2007-05-02
RU2007108666A (ru) 2008-09-20
HK1109579A1 (en) 2008-06-13
CN101022811B (zh) 2010-09-15
ZA200702038B (en) 2008-08-27
CN101022811A (zh) 2007-08-22
AU2005271206B2 (en) 2009-11-26
EP1848441B1 (de) 2010-04-14
BRPI0513938B1 (pt) 2018-09-25
IL180899A0 (en) 2007-07-04
CA2574997A1 (en) 2006-02-16
MA28844B1 (fr) 2007-09-03
ATE464053T1 (de) 2010-04-15
BRPI0513938B8 (pt) 2021-05-25
WO2006015956A1 (en) 2006-02-16
EP1848441A1 (de) 2007-10-31

Similar Documents

Publication Publication Date Title
DE602005020694D1 (de) Pharmazeutische zusammensetzung mit drospirenon und ethinylöstradiol
GB0413730D0 (en) A pharmaceutical composition and its use
IL179795A0 (en) A pharmaceutical composition and its use
EP1828223A4 (de) Neue betulinderivate, deren herstellung und deren verwendung
EP1800685A4 (de) Pharmazeutische steroide saponin-zusammensetzung, ihr herstellungsverfahren und ihre verwendung
ATE555791T1 (de) Pharmazeutische zusammensetzung enthaltend gestagene und/oder estrogene und 5-methyl-(6s)- tetrahydrofolat
IL176538A0 (en) Steroid derivatives and pharmaceutical compositions containing the same
GB0523576D0 (en) Drug composition and its use in therapy
IL183583A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
EP1940361A4 (de) Pharmazeutische dosierformen mit sofortiger freisetzung und/oder kontrollierter freisetzung
IL180284A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
EP1808446A4 (de) Il-18-rezeptor-antagonist und pharmazeutische zusammensetzung mit dem antagonisten
EP1890677A4 (de) Pharmazeutische zusammensetzungen und ihre verwendung
IL178067A0 (en) Pharmaceutical dosage forms and compositions
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
TWI350287B (en) Acylaminothiazole derivatives, their preparation and their therapeutic application
GB0516069D0 (en) Pharmaceutical and use thereof
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
DE60305728D1 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG
IL179669A0 (en) Benzoimidazole derivatives and pharmaceutical compositions containing the same
DE602005012287D1 (de) Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung
ZA200704806B (en) Novel betulin derivatives, preparation thereof and use thereof
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
DE502006003892D1 (de) Perorale Arzneiform mit Dienogest und Ethinylestradiol zur Kontrazeption

Legal Events

Date Code Title Description
8363 Opposition against the patent